Acuta Capital Partners, LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Acuta Capital Partners, LLC

  • $92.9 Million
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2018

May 15, 2018
SELL
$22.47 - $32.33 $1.8 Million - $2.59 Million
-80,000 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$26.84 - $39.14 $268,400 - $391,400
10,000 Added 14.29%
80,000 $2.41 Million
Q3 2017

Nov 14, 2017
BUY
$29.49 - $38.37 $2.06 Million - $2.69 Million
70,000
70,000 $2.64 Million

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.54B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email